Executive Conference Corporation
The mission of ECC Webinars is to provide the pharmaceutical, biotech, and medical device industries with leading edge and informative webinars led by experts in their fields, fostering a stronger knowledge base in the workforce.
"The Difference is Distictive"
Webinars
Archived ECC Webinars
| ECC # | DATE | TITLE | Instructor(s) |
|---|---|---|---|
| ECC-758 | 2026-07-08 | The Microbiology of Water in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-755 | 2026-06-30 | THE BACTERIAL ENDOTOXINS TEST (ISSUES AND SOLUTIONS) TO INCLUDE THE ISSUE OF LOW ENDOTOXIN RECOVERY (LER) AND TR 82 (PDA) AND GENERAL INFORMATION CHAPTER <1085> | Barry A. Friedman Ph.D |
| ECC-754 | 2026-06-23 | Risk Management of Raw Materials in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-752 | 2026-06-18 | Good Laboratory Practices (GLP) vs. Good Manufacturing Practices (GMPs) — A Comparison and Contrast – “Why One Should Use Only GMP Facilities for Manufacturing and Testing” | Barry A. Friedman Ph.D |
| ECC-753 | 2026-06-17 | Managing Microbiological Out of Specification (OOS) and Out of Trend (OOT) Results in Sterile and Non-Sterile Production FDA and ICH Expectations and Guidance | Barry A. Friedman Ph.D |
| ECC-742 | 2026-06-16 | Effective Technical Writing | Greg Smith |
| ECC-744 | 2026-05-27 | Development of a Steam Autoclave Sterilization Validation Plan | Barry A. Friedman Ph.D |
| ECC-745 | 2026-05-21 | Risk Management of Raw Materials in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-743 | 2026-05-20 | USP 61/62 Microbiological Enumeration & Examination of Non-Sterile Products | Barry A. Friedman Ph.D |
| ECC-746 | 2026-05-19 | Pharmaceutical Compressed Air - Quality GMP Standards and Requirements | Roger Cowan |
| ECC-741 | 2026-04-30 | Annual Laboratory Microbiology Training | Barry A. Friedman Ph.D |
| ECC-730 | 2026-04-23 | How to Develop a Holistic Contamination Control Strategy for ATMP Cleanrooms | Jim Polarine |
| ECC-732 | 2026-04-22 | THE BACTERIAL ENDOTOXINS TEST (ISSUES AND SOLUTIONS) TO INCLUDE THE ISSUE OF LOW ENDOTOXIN RECOVERY (LER) AND TR 82 (PDA) AND GENERAL INFORMATION CHAPTER <1085> | Barry A. Friedman Ph.D |
| ECC-740 | 2026-04-21 | The Microbiology of Water in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-739 | 2026-04-15 | Process Simulation Testing for Aseptically Filled Products; An In-depth Examination of the Latest Product Sterility Assurance Levels Prescribed by GMPs | Barry A. Friedman Ph.D |
| ECC-727 | 2026-04-14 | A Roadmap to a Successful Contamination Control Strategy (CCS): Covering Annex I Updates and FDA Warning Letters and 483’s | Jim Polarine |
| ECC-738 | 2026-04-09 | Bioburden Control of Non-Sterile Drug Substances and Products– A New USP General Information Chapter | Barry A. Friedman Ph.D |
| ECC-737 | 2026-04-08 | VALIDATION MASTER PLANNING (DEVELOPING A COMPREHENSIVE VALIDATION PACKAGE) | Barry A. Friedman Ph.D |
| ECC-736 | 2026-04-07 | GMP Environmental Monitoring for Pharmaceutical Clean Rooms | Roger Cowan |
| ECC-735 | 2026-03-24 | USP <51> Antimicrobial Effectiveness Testing – A Revised Chapter | Barry A. Friedman Ph.D |
| ECC-734 | 2026-03-18 | MICROBIOLOGY FOR THE NON-MICROBIOLOGIST – AND THE MICROBIOLOGIST WHO DESIRES A GMP MICROBIOLOGICAL REFRESHER | Barry A. Friedman Ph.D |
| ECC-733 | 2026-03-17 | Risk Management of Raw Materials in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-731 | 2026-03-12 | Investigating OOS results | Danielle DeLucy |
| ECC-729 | 2026-03-03 | CMO Supplier Quality Agreements – How to Comply with new FDA and EU Guidelines for Contract Drug Manufacture | Roger Cowan |
| ECC-728 | 2026-02-25 | USP <51> Antimicrobial Effectiveness Testing – A Revised Chapter | Barry A. Friedman Ph.D |
| ECC-726 | 2026-02-19 | FDA Contract Manufacturing Arrangements for Drugs: Quality Agreements - Their Relationship to Microbiological Issues | Barry A. Friedman Ph.D |
| ECC-725 | 2026-02-18 | Annual Laboratory Microbiology Training | Barry A. Friedman Ph.D |
| ECC724 | 2026-02-17 | CAPA/Root Cause Analysis: Achieving Compliance with Proper CAPA Systems | Danielle DeLucy |
| ECC723 | 2026-02-12 | Development of a Steam Autoclave Sterilization Validation Plan | Barry A. Friedman Ph.D |
| ECC-722 | 2026-02-03 | Pharmaceutical Compressed Air - Quality GMP Standards and Requirements | Roger Cowan |
| ECC-721 | 2026-01-29 | Effective Batch Record Review | Danielle DeLucy |
| ECC-720 | 2026-01-28 | Hot Topics in the Cleanroom Industry, Biodecontamination of RABS and Isolators, Materials Transfer and Disinfectant Field Trials | Jim Polarine |
| ECC-719 | 2026-01-22 | The Microbiology of Water in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-718 | 2026-01-21 | Process Simulation Testing for Aseptically Filled Products; An In-depth Examination of the Latest Product Sterility Assurance Levels Prescribed by GMPs | Barry A. Friedman Ph.D |
| ECC-716 | 2026-01-20 | Sterile Filtration of Pharmaceutical Products – Validation and Regulatory Requirements | Roger Cowan |
| ECC-717 | 2026-01-15 | Risk Management of Raw Materials in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-715 | 2026-01-13 | VALIDATION MASTER PLANNING (DEVELOPING A COMPREHENSIVE VALIDATION PACKAGE) | Barry A. Friedman Ph.D |
| ECC-713 | 2025-12-18 | Bioburden Control of Non-Sterile Drug Substances and Products– A New USP General Information Chapter | Barry A. Friedman Ph.D |
| ECC-712 | 2025-12-16 | USP 61/62 Microbiological Enumeration & Examination of Non-Sterile Products | Barry A. Friedman Ph.D |
| ECC-714 | 2025-12-11 | HVAC and GMP Environmental Control for Pharmaceutical Clean Rooms | Roger Cowan |
| ECC-711 | 2025-12-10 | Managing Microbiological Out of Specification (OOS) and Out of Trend (OOT) Results in Sterile and Non-Sterile ProductionFDA and ICH Expectations and Guidance | Barry A. Friedman Ph.D |
| ECC-710 | 2025-12-03 | Good Laboratory Practices (GLP) vs. Good Manufacturing Practices (GMPs) — A Comparison and Contrast – “Why One Should Use Only GMP Facilities for Manufacturing and Testing” | Barry A. Friedman Ph.D |
| ECC-705 | 2025-11-20 | MICROBIOLOGY FOR THE NON-MICROBIOLOGIST – AND THE MICROBIOLOGIST WHO DESIRES A GMP MICROBIOLOGICAL REFRESHER | Barry A. Friedman Ph.D |
| ECC-709 | 2025-11-13 | Sterile Filtration of Pharmaceutical Products – Validation and Regulatory Requirements | Roger Cowan |
| ECC-703 | 2025-11-12 | Risk Management of Raw Materials in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-702 | 2025-11-05 | The Microbiology of Water in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-708 | 2025-11-04 | Hot Topics in the Cleanroom Industry, Biodecontamination of RABS and Isolators, Materials Transfer and Disinfectant Field Trials | Jim Polarine |
| ECC-701 | 2025-10-29 | VALIDATION MASTER PLANNING (DEVELOPING A COMPREHENSIVE VALIDATION PACKAGE) | Barry A. Friedman Ph.D |
| ECC-707 | 2025-10-23 | GMP Environmental Monitoring for Pharmaceutical Clean Rooms | Roger Cowan |
| ECC-700 | 2025-10-22 | THE BACTERIAL ENDOTOXINS TEST (ISSUES AND SOLUTIONS) TO INCLUDE THE ISSUE OF LOW ENDOTOXIN RECOVERY (LER) AND TR 82 (PDA) AND GENERAL INFORMATION CHAPTER <1085> | Barry A. Friedman Ph.D |
| Page: | 1 | 2 | 3 | | |||